Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation: A Meta‐Analysis

作者: V. C. McAlister , E. Haddad , E. Renouf , R. A. Malthaner , M. S. Kjaer

DOI: 10.1111/J.1600-6143.2006.01360.X

关键词: CiclosporinMedicineTacrolimusGastroenterologyCalcineurinAntibacterial agentImmunosuppressionTransplantationRandomized controlled trialSurgeryLiver transplantationInternal medicine

摘要: A systematic review of randomized clinical trials (RCT) was undertaken to evaluate the beneficial and harmful effects immunosuppression with cyclosporin versus tacrolimus for liver transplanted patients. MEDLINE, EMBASE, Cochrane Central Hepato-Biliary Group Controlled Trials Registers were searched. Using fixed random model, relative risk (RR), values <1 favoring tacrolimus, 95% confidence intervals (CI) calculated. Of 717 potentially relevant references, 16 RCTs eligible inclusion. Mortality graft loss at 1 year significantly reduced in tacrolimus-treated recipients (Death: RR 0.85, CI 0.73-0.99; loss: 0.73, 0.61-0.86). Tacrolimus number acute rejection (RR 0.81, 0.75-0.88) steroid-resistant 0.54, 0.47-0.74) first year. Lymphoproliferative disorder or dialysis rates not different but more de novo diabetes 1.38, 1.01-1.86) occurred tacrolimus. More patients stopped than 0.57, 0.49-0.66). Treating 100 instead would avoid nine seven respectively, death five two four additional develop after transplantation.

参考文章(29)
Michael Eliasziw, Ashok Jain, Allan Donner, John J. Fung, Thomas E. Starzl, John P. McMichael, Paul Meier, Satoru Todo, Anthony J. Demetris, The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. Journal of The American College of Surgeons. ,vol. 183, pp. 117- 125 ,(1996)
Thomas Starzl, Shunzaburo Iwatsuki, Byers Shaw, Robert Gordon, Carlos Esquivel, Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Seminars in Liver Disease. ,vol. 5, pp. 334- 343 ,(1985) , 10.1055/S-2008-1040630
W Timmermann, J Erhard, R Lange, T Reck, F Köckerling, A Müller, C Jung, K.H Dietl, B Kremer, G Kirste, W Schareck, M Golling, E Klar, A randomised trial comparing the efficacy and safety of tacrolimus with microemulsified cyclosporine after liver transplantation. International Congress on Immunosuppression. ,vol. 34, pp. 1516- 1518 ,(2002) , 10.1016/S0041-1345(02)02953-6
T.E Starzl, J.J Fung, J.P McMichael, S Todo, A Donner, M Eliasziw, L Stitt, P Meier, Randomised trialomania? The multicentre liver transplant trials of tacrolimus The Lancet. ,vol. 346, pp. 1346- 1350 ,(1995) , 10.1016/S0140-6736(95)92349-7
Bo-G??ran Ericzon, Sharif Eusufzai, Gunnar S??derdahl, Frans Duraj, Kurt Einarsson, Bo Angelin, Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. Transplantation. ,vol. 63, pp. 74- 80 ,(1997) , 10.1097/00007890-199701150-00014
John J Siekierka, Nolan H Sigal, FK-506 AND CYCLOSPORIN A : IMMUNOSUPPRESSIVE MECHANISM OF ACTION AND BEYOND Current Opinion in Immunology. ,vol. 4, pp. 548- 552 ,(1992) , 10.1016/0952-7915(92)90024-9
F Mühlbacher, Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. World Congress of the Transplantation Society. ,vol. 33, pp. 1339- 1340 ,(2001) , 10.1016/S0041-1345(00)02500-8
Mark D. Stegall, Michael E. Wachs, Gregory Everson, Tracy Steinberg, Bahri Bilir, Roshan Shrestha, Frederick Karrer, Igal Kam, Prednisone withdrawal 14 days after liver transplantation with mycophenolate a prospective trial of cyclosporine and tacrolimus Transplantation. ,vol. 64, pp. 1755- 1760 ,(1997) , 10.1097/00007890-199712270-00023
Kareem Abu-Elmagd, H. Doyle, L. Mieles, A. Stieber, S. Todo, A. Jain, A. Casavilla, R. Selby, A. Tzakis, J. Reyes, T. Starzl, S. Takaya, M. Martin, J. Fung, R. Gordon, O. Bronster, A. Demetris, M. Alessiani, A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine Transplantation Society. International congress. ,vol. 23, pp. 2977- 2983 ,(1991)